EXPANDED ACCESS TO INVESTIGATIONAL DRUGS POLICY
2051. PURPOSE This document describes KOUSAI´s position, and reflects our Corporate Policy on how patients in medical need may be able to access our new medicines before they are fully approved for use on prescription. 2. SCOPE We cover ...
View details
恒赛生物

